The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy and ...

The exact binding site on the ribosomes was previously unknown, and the study revealed a novel mechanism through which future drugs could potentially override the erroneous stop signal.

The exact binding site on the ribosomes was previously unknown, and the study revealed a novel mechanism through which future drugs could potentially override the erroneous stop signal.

The global immunotoxins market was valued at USD 159.9 million in 2024 and is projected to expand at a compound annual growth ...

Although the positive effects of mefloquine on aminoglycosides were already known, the current study revealed the way mefloquine binds to the ribosomes, the cell organelle where proteins are produced.

This article delves into the application of nitrogen compounds in antibiotic research and development, illustrating how they influence antibiotic efficacy. Fundamental Properties of Nitrogen Compounds ...

A team of international researchers led by Karolinska Institutet has revealed in unprecedented detail how tetracycline ...

This manuscript characterizes a mutated clone of RNA polymerase I in yeast, referred to as SuperPol, to understand the mechanisms of RNA polymerase I elongation and termination. The authors present ...

The interaction between RNA-binding proteins (RBPs) and circular RNAs (circRNAs) has emerged as a key area of interest in understanding cancer biology.